Previous studies reported that SNHG3 is upregulated in cancers and may act as an oncogene in tumor prognosis, including osteosarcoma [19], glioma [20], ovarian cancers [21], breast cancer [22], and hepatocellular carcinoma [23]. This evidence concerns the gene SNHG3 and cancer.